Page last updated: 2024-11-08

2-(sec-butyl)-4,5-dihydrothiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(sec-butyl)-4,5-dihydrothiazole: volatile pheromone constituent of male mouse urine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID162148
CHEMBL ID3337494
SCHEMBL ID593348
MeSH IDM0141452

Synonyms (23)

Synonym
thiazole, 4,5-dihydro-2-(1-methylpropyl)-
2-sec-butyl-4,5-dihydrothiazole
4,5-dihydro-2-(1-methylpropyl)thiazole
2-(sec-butyl)-4,5-dihydrothiazole
56367-27-2
2-(sec-butyl)thiazoline
FT-0691857
2-butan-2-yl-4,5-dihydro-1,3-thiazole
le756qg3f5 ,
unii-le756qg3f5
SCHEMBL593348
AKOS028108640
CHEMBL3337494
2-s-butyl-4,5-dihydrothiazole
Q4596972
AS-44352
2-(1-methylpropyl)-4,5-dihydrothiazole
2-sec-butylthiazoline
mfcd28044285
DTXSID00971802
CS-0152625
SY269910
2-(butan-2-yl)-4,5-dihydro-1,3-thiazole

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" When dosed orally to F344 rats, DHT (1 mmol/kg for 3 days) caused the characteristic exacerbation of hyaline droplets in male rat kidneys and increased renal levels of immunoreactive alpha 2u-globulin about threefold over control levels."( 2-sec-butyl-4,5-dihydrothiazole is a ligand for mouse urinary protein and rat alpha 2u-globulin: physiological and toxicological relevance.
Caudill, D; Eddy, C; Lehman-McKeeman, LD; Rodriguez, PA, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1179554Binding affinity to mouse major urinary protein by NMR analysis2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Elements and modulation of functional dynamics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's8 (42.11)18.2507
2000's6 (31.58)29.6817
2010's4 (21.05)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.42 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (10.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (89.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]